Prostanozol
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| Identifiers | |
| ATC code | None |
| UNII |
JNU1579M5D  |
| Chemical data | |
| Formula | C25H38N2O2 |
| Molar mass | 398.580 g/mol |
| |
| (verify) | |
Prostanozol is an anabolic steroid designer drug which is a prodrug of the 17-demethylated analogue of stanozolol (Winstrol). It was found in 2005 as an ingredient of products sold as "dietary supplements" for bodybuilding.[1]
It is one of hundreds of drugs banned from the Olympics by the IOC.[2] Russian marathon runner Lyubov Denisova was banned for two years from competition after testing positive for prostanozol and testosterone in 2007.[3]
References
- ↑ Eenoo PV, Delbeke FT. Metabolism and excretion of anabolic steroids in doping control—New steroids and new insights. Journal of Steroid Biochemistry and Molecular Biology. 2006;101(4-5):161-178. doi:10.1016/j.jsbmb.2006.06.024
- ↑ "192 Banned Performance Enhancing Substances and Methods". ProCon.org. March 17, 2010. Retrieved July 25, 2015.
- ↑ "Russian marathon runner Denisova banned for 2 years for doping". USA Today. May 15, 2007. Retrieved July 25, 2015.
This article is issued from Wikipedia - version of the Sunday, July 26, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.